Latest Articles

Publication Date
Surgical de-escalation trends in gynecologic oncology - Contemporary Obgyn

Surgical de-escalation trends in gynecologic oncology Contemporary Obgyn

Published: Jan. 9, 2025, 5:10 p.m.
Research Bolsters Need for Enhanced Surveillance After Radiotherapy for Endometrial Cancer - Oncology Nurse Advisor

Research Bolsters Need for Enhanced Surveillance After Radiotherapy for Endometrial Cancer Oncology Nurse Advisor

Published: Dec. 23, 2024, 5 p.m.
The Targeted Pulse: Don’t Miss the FDA’s Latest Treatment Decisions and What a Retrospective Study Revealed in Endometrial Cancer - Targeted Oncology

The Targeted Pulse: Don’t Miss the FDA’s Latest Treatment Decisions and What a Retrospective Study Revealed in Endometrial Cancer Targeted Oncology

Published: Dec. 8, 2024, 5 p.m.
Dramatic Spike in Molecular Testing for Endometrial Cancer Tells “Positive Story” - Oncology News Central

Dramatic Spike in Molecular Testing for Endometrial Cancer Tells “Positive Story” Oncology News Central

Published: Dec. 5, 2024, 12:54 p.m.
Dramatic Spike in Molecular Testing for Endometrial Cancer Tells “Positive Story” - oncologynewscentral.com

Dramatic Spike in Molecular Testing for Endometrial Cancer Tells “Positive Story” oncologynewscentral.com

Published: Dec. 5, 2024, 12:54 p.m.
Recommendations and Future Directions of Genetic Testing for CLL - Targeted Oncology

Recommendations and Future Directions of Genetic Testing for CLL Targeted Oncology

Published: Dec. 3, 2024, 1 a.m.
Proposal for Managing Cancer-Related Insomnia: A Systematic Literature Review of Associated Factors and a Narrative Review of Treatment.

Insomnia is common in patients with cancer. It has a multifactorial etiology that may include the disease process, adverse effects of anticancer therapies, and/or an association with other comorbidities. The …

Published: Nov. 27, 2024, midnight
3 FDA Approvals Signal Year of Change for Endometrial Cancer Care - Oncology News Central

3 FDA Approvals Signal Year of Change for Endometrial Cancer Care Oncology News Central

Published: Nov. 13, 2024, 11:41 a.m.
3 FDA Approvals Signal Year of Change for Endometrial Cancer Care - oncologynewscentral.com

3 FDA Approvals Signal Year of Change for Endometrial Cancer Care oncologynewscentral.com

Published: Nov. 13, 2024, 11:41 a.m.
Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - The Manila Times

Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium The Manila Times

Published: Oct. 23, 2024, 10:06 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!